Company intelligence

Precision Neuroscience

Biotech
Last verified Sep 24, 2026

Key Metrics

Valuation
~$1B
As of Sep 24, 2026GlobeNewswire
Total funding
$430M
As of Sep 24, 2026GlobeNewswire

Company Snapshot

Precision Neuroscience is a Biotech company. Latest valuation ~$1B (As of Sep 24, 2026, GlobeNewswire). Total funding $430M (As of Sep 24, 2026).

Recent changes

  1. Sep 25, 2026Precision Neuroscience Raises $250M For Brain Implants Pulse story
  2. Sep 24, 2026Raised $250M Series D at a ~$1B valuation GlobeNewswire
  3. Sep 24, 2026First reported valuation: ~$1B GlobeNewswire
  4. Sep 24, 2026First reported total funding: $430M GlobeNewswire
  5. Sep 24, 2026New investor: Invus GlobeNewswire
Earlier changes (6)
  1. Sep 24, 2026New investor: ARK Invest GlobeNewswire
  2. Sep 24, 2026New investor: Mubadala Capital GlobeNewswire
  3. Sep 24, 2026New investor: B Capital GlobeNewswire
  4. Sep 24, 2026New investor: Korea Investment Partners GlobeNewswire
  5. Sep 24, 2026Precision Neuroscience Hits $1B Valuation On $250M Raise Pulse story
  6. Sep 24, 2026Ackman Co-Leads Precision Neuroscience's $250M Round Pulse story

Funding History

1 event · sources dated per row
DateEventAmountValuationInvestorsSource
Sep 24, 2026Series D$250M~$1B
B CapitalARK InvestInvusMubadala CapitalKorea Investment PartnersPershing Square Inc.Ackman Oxman InstituteDuquesne Family OfficeMirae Asset Capital+2 more
GlobeNewswire

Investors

Latest Pulse

  1. OpenEvidence Raises $250M Led By Andreessen HorowitzOpenEvidence, the Miami-based clinical search platform for physicians, raised a new $250 million round led by hospital systems and Andreessen Horowitz.→
  2. Precision Neuroscience Raises $250M For Brain ImplantsPrecision Neuroscience raised $250 million to advance its brain-computer interface technology, backed by Bill Ackman's Pershing Square and the Ackman Oxman Institute.→
  3. AI Agent Security Just Had A $1.15B WeekIsland, Cyera and BigHat Biosciences alone raised more than $1.1 billion this week to build the layer that governs what AI agents can access and do -- evidence the market has already priced in the exact failure mode this issue's lead story just demonstrated.→
  4. Precision Neuroscience Hits $1B Valuation On $250M RaisePrecision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square and his new Ackman Oxman Institute, valuing the brain-computer interface company at just over $1 billion.→
  5. Ackman Co-Leads Precision Neuroscience's $250M RoundPrecision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square, valuing the brain-computer interface company at just over $1 billion as it scales past 100 patient procedures.→

Coverage Timeline

newest first
  1. Sep 25, 2026FUNDINGPrecision Neuroscience Raises $250M For Brain Implants$250M Series D→
  2. Sep 24, 2026FUNDINGPrecision Neuroscience Hits $1B Valuation On $250M Raise$250M Series D→
  3. Sep 24, 2026FUNDINGAckman Co-Leads Precision Neuroscience's $250M Round$250M Series D→

All Coverage

Related Companies

Precision Neuroscience FAQ

What is Precision Neuroscience's valuation?

Precision Neuroscience's valuation is ~$1B (As of Sep 24, 2026, GlobeNewswire).

How much has Precision Neuroscience raised?

Precision Neuroscience has raised $430M in total funding (As of Sep 24, 2026, GlobeNewswire).

Who are Precision Neuroscience's investors?

Precision Neuroscience's investors include ARK Invest, B Capital, Invus, Korea Investment Partners, Mubadala Capital (As of Sep 24, 2026).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction